Blood cancer patients, especially when they relapse, have a poor prognosis, and generally do not survive very long. The last five years have seen success in treating these patients with Chimeric Antigen Receptor (CAR) T-cells—a ...
Feb 24, 2023
0
50
Researchers said Tuesday they have identified a particularly severe form of mpox in people with advanced HIV which had a death rate of 15 percent among patients with AIDS.
Feb 21, 2023
0
88
Universitätsklinikum Erlangen is the first in the world to use CAR T-cells to successfully treat a patient suffering from a severe case of muscle inflammation (myositis). The disease is triggered by a malfunction in the ...
Feb 20, 2023
0
104
For someone previously infected with COVID-19, their risk of hospitalization or death is 88% lower for at least 10 months compared to those who had not been previously infected, according to a systematic review and meta-analysis ...
Feb 16, 2023
0
82
A Lancet Series published on Feb. 8, 2023, highlights the continuing struggle that women across the globe face to meet their breastfeeding goals. Yale School of Public Health Professor Rafael Pérez-Escamilla, a leading authority ...
Feb 10, 2023
0
42
No new variants of COVID-19 emerged in Beijing in the weeks after China ended its zero-COVID policy late last year, a new study said on Wednesday.
Feb 8, 2023
0
68
Patients can experience 30% fewer serious adverse reactions if their drugs are tailored to their genes, reports a study published in The Lancet. A European collaboration involving researchers from Karolinska Institutet suggests ...
Feb 3, 2023
0
64
One third of premature deaths attributable to higher temperatures in European cities during summer 2015 could have been prevented by increasing urban tree cover to 30%, reveals a modeling study published in The Lancet. The ...
Jan 31, 2023
0
120
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers ...
Jan 30, 2023
0
59
Patients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anemia and spleen enlargement, when treated with the targeted therapy momelotinib, according to results from the international ...
Jan 29, 2023
0
35
